Abstract
There are several treatment options for localized prostate cancer with very similar outcome but vary in terms of technique and side effect profiles and risks. Considering the potential difficulty in choosing the best treatment, a patient decision aid (PDA) is used to help patients in their decision-making process. However, the use and applicability of PDA in a country in Asia Pacific region like Malaysia is still unknown. This study aims to evaluate the effectiveness of a PDA modified to the local context in improving patients’ knowledge, decisional conflict, and preparation for decision making among men with localized prostate cancer. Sixty patients with localized prostate cancer were randomly assigned to control and intervention groups. A self-administered questionnaire, which evaluate the knowledge on prostate cancer (23 items), decisional conflict (10 items) and preparation for decision-making (10 items), was given to all participants at pre- and post-intervention. Data were analyzed using independent T test and paired T test. The intervention group showed significant improvement in knowledge (p = 0.02) and decisional conflict (p = 0.01) from baseline. However, when compared between the control and intervention groups, there were no significant differences at baseline and post-intervention on knowledge, decisional conflict and preparation for decision-making. A PDA on treatment options of localized prostate cancer modified to the local context in an Asia Pacific country improved patients’ knowledge and decisional conflict but did not have significant impact on the preparation for decision-making. The study was also registered under the Australian New Zealand Clinical Trials Registry (ANZCTR), ACTRN12614000668606 registered on 25/06/2014.
Similar content being viewed by others
References
Ferlay J, Soerjomataram I, Dikshit R, Eser S, Mathers C, Rebelo M, Parkin DM, Forman D, Bray F (2015) Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012. Int J Cancer 136(5):E359–E386. https://doi.org/10.1002/ijc.29210
WHO 2019. Malaysia Cancer Fact Sheets. 2019 http://gco.iarc.fr/today/data/factsheets/populations/458-malaysia-fact-sheets.pdf.Access 13 January 2020
Heidenreich A, Bastian PJ, Bellmunt J, Bolla M, Joniau S, van der Kwast T, Mason M, Matveev V, Wiegel T, Zattoni F, Mottet N, European Association of Urology (2014) EAU guidelines on prostate cancer. part 1: screening, diagnosis, and local treatment with curative intent-update 2013. Eur Urol 65(1):124–137 https://doi.org/10.1016/j.eururo.2013.09.046
Mottet N, Bellmunt J, Bolla M, Briers E, Cumberbatch MG, De Santis M et al (2017) EAU-ESTRO-SIOG guidelines on prostate cancer. Part 1: screening, diagnosis, and local treatment with curative intent. Eur Urol 71(4):618–629. https://doi.org/10.1016/j.eururo.2016.08.003
Chapple A, ZieblandS (2002) Prostate cancer: embodied experience and perceptions of masculinity. Sociology of Health & Illness 24(6):820–841
Steginga SK, Occhipinti S, Gardiner RA, Yaxley J, Heathcote P (2002) Making decisions about treatment for localized prostate cancer. BJU Int 89(3):255–260. https://doi.org/10.1046/j.1464-4096.2001.01741.x
Lee YK, Lee PY, Cheong AT, Ng CJ, Abdullah KL, Ong TA et al (2015) To share or not to share: Malaysian healthcare professionals’ views on localized prostate cancer treatment decision making roles. PLoS ONE 10(11):e0142812. https://doi.org/10.1371/journal.pone.0142812
O’Connor AM, Rostom A, Fiset V, Tetroe J, Entwistle V, Llewellyn-Thomas H et al (1999) Decision aids for patients facing health treatment or screening decisions: systematic review. BMJ 319(7212):731–734. https://doi.org/10.1136/bmj.319.7212.731
Brink SG, Birney AJ, McFarren AE (2000) Charting your course: formative evaluation of a prostate cancer treatment decision aid. Int Electron J Health Educ 3(11):44–54
Berry DL, Halpenny B, Hong F, Wolpin S, Lober WB, Russell KJ et al (2013) The personal patient profile-prostate decision support for men with localized prostate cancer: a multi-center randomized trial. Urologic Oncology 31(7):1012–1021. https://doi.org/10.1016/j.urolonc.2011.10.004
Queensland University. Decision aid computer program for early-stage prostate cancer patients. https://qcri.queensu.ca/cancer-care-epidemiology/resources/patients Access 22 May 2020
Agency for Healthcare Research and Quality (AHRQ). Knowing your options: a decision aid for men with clinically localised prostate cancer. 2012. https://effectivehealthcare.ahrq.gov/products/decision-aids/prostate-cancer Accessed 22 May 2020
National Cancer Institute. Treatment choices for men with early-stage prostate cancer. https://www.cancer.gov/publications/patient-education/understanding-prostate-cancer-treatment Accessed 22 May 2020
Michigan cancer consortium. Making the choices. http://www.prostatecancerdecision.org/index.htm Accessed 22 May 2020
Cheong AT, Lee PY, Ng CJ, Lee YK, Ong TA, Abdullah KL et al (2016) Doctors’ approaches to decision support in counseling patients with localized prostate cancer: an Asian perspective. Sains Malaysiana 45(6):941–947
Lee PY, Cheong AT, Ng CJ, Lee YK, Abdullah KL, Razack AHA et al (2016) Supporting patients in making treatment decisions for early prostate cancer: a qualitative study of healthcare professionals’ views on barriers and challenges in an Asian country. J Men's Health 12(1):20–26
Suresh KP (2011) An overview of randomization techniques: an unbiased assessment of outcome in clinical research. J Hum Reprod Sci 4(1):8–11. https://doi.org/10.4103/0974-1208.82352
Snedecor GW, Cochan WG 1989. Statistical methods, eighth edition. 8 ed. Iowa State University Press
Chabrera C, Zabalegui A, Bonet M, Caro M, Areal J, Gonzalez JR et al (2015) A decision aid to support informed choices for patients recently diagnosed with prostate cancer: a randomized controlled trial. Cancer Nurs 38(3):E42–E50. https://doi.org/10.1097/NCC.0000000000000170
Lee PY, Ng CJ, Lee YK, et al. 2014. Making the choice, deciding what to do about early stage prostate cancer
O’Connor AM, Tugwell P, Wells GA, Elmslie T, Jolly E, Hollingworth G, McPherson R, Bunn H, Graham I, Drake E (1998) A decision aid for women considering hormone therapy after menopause: decision support framework and evaluation. Patient Educ Couns 33(3):267–279. https://doi.org/10.1016/s0738-3991(98)00026-3
Taylor KL, Davis KM, Lamond T, Williams RM, Schwartz MD, Lawrence W, Feng S, Brink S, Birney A, Lynch J, Regan J, Dritschilo A (2010) Use and evaluation of a CD-ROM-based decision aid for prostate cancer treatment decisions. Behav Med 36(4):130–140. https://doi.org/10.1080/08964289.2010.525263
O'Connor AM (1995) Validation of a decisional conflict scale. Med Decis Mak 15(1):25–30. https://doi.org/10.1177/0272989X9501500105
Bennett C, Graham ID, Kristjansson E, Kearing SA, Clay KF, O'Connor AM (2010) Validation of a preparation for decision making scale. Patient Educ Couns 78(1):130–133. https://doi.org/10.1016/j.pec.2009.05.012
Daum LM, Reamer EN, Ruterbusch JJ, Liu J, Holmes-Rovner M, Xu J (2017) Patient knowledge and qualities of treatment decisions for localized prostate cancer. J Am Board Fam Med 30(3):288–297. https://doi.org/10.3122/jabfm.2017.03.160298
Arnold-Reed DE, Hince DA, Bulsara MK, Ngo H, Eaton M, Wright AR, Jones FR, Kaczmarczyk W, Marangou AG, Brett TD (2008) Knowledge and attitudes of men about prostate cancer. Med J Aust 189(6):312–314 https:doi.org/https://doi.org/10.5694/j.1326-5377.2008.tb02047.x
Suriani I, Huda Z, Titi RH, Muhammad HJ, Nor Afiah MZ, Suhainizam MS (2018) Factors associated with awareness, knowledge and attitude towards prostate cancer among Malay men in traditional Malay villages, Negeri Sembilan, Malaysia. Malaysian Journal of Medicine and Health Sciences 14(2):31–38
Lin GA, Aaronson DS, Knight SJ, Carroll PR, Dudley RA (2009) Patient decision aids for prostate cancer treatment: a systematic review of the literature. CA Cancer J Clin 59(6):379–390. https://doi.org/10.3322/caac.20039
Snow SL, Panton RL, Butler LJ, Wilke DR, Rutledge RD, Bell DG et al (2007) Incomplete and inconsistent information provided to men making decisions for treatment of early-stage prostate cancer. Urology 69(5):941–945. https://doi.org/10.1016/j.urology.2007.01.027
Zeliadt SB, Ramsey SD, Penson DF, Hall IJ, Ekwueme DU, Stroud L, Lee JW (2006) Why do men choose one treatment over another?: a review of patient decision making for localized prostate cancer. Cancer 106(9):1865–1874. https://doi.org/10.1002/cncr.21822
Onel E, Hamond C, Wasson JH, Berlin BB, Ely MG, Laudone VP, Tarantino AE, Albertsen PC (1998) Assessment of the feasibility and impact of shared decision making in prostate cancer. Urology 51(1):63–66. https://doi.org/10.1016/s0090-4295(97)00494-9
van Tol-Geerdink JJ, Leer JW, van Lin EN, Schimmel EC, Huizenga H, van Daal WA et al (2008) Offering a treatment choice in the irradiation of prostate cancer leads to better informed and more active patients, without harm to well-being. Int J Radiat Oncol Biol Phys 70(2):442–448. https://doi.org/10.1016/j.ijrobp.2007.06.058
Holmes-Rovner M, Stableford S, Fagerlin A, Wei JT, Dunn RL, Ohene-Frempong J, Kelly-Blake K, Rovner DR (2005) Evidence-based patient choice: a prostate cancer decision aid in plain language. BMC Med Inform Decis Mak 5:1–16. https://doi.org/10.1186/1472-6947-5-16
Feldman-Stewart D, Tong C, Siemens R, Alibhai S, Pickles T, Robinson J (2012) The impact of explicit values clarification exercises in a patient decision aid emerges after the decision is actually made: evidence from a randomized controlled trial. Med Decis Mak 32(4):616–626. https://doi.org/10.1177/0272989X11434601
Aning JJ, Wassersug RJ, Goldenberg SL (2012) Patient preference and the impact of decision-making aids on prostate cancer treatment choices and post-intervention regret. Curr Oncol 19(Suppl 3):S37–S44. https://doi.org/10.3747/co.19.1287
Wang EH, Gross CP, Tilburt JC, Yu JB, Nguyen PL, Smaldone MC, Shah ND, Abouassally R, Sun M, Kim SP (2015) Shared decision making and use of decision AIDS for localized prostate cancer : perceptions from radiation oncologists and urologists. JAMA Intern Med 175(5):792–799. https://doi.org/10.1001/jamainternmed.2015.63
Davison BJ, Goldenberg SL, Wiens KP, Gleave ME (2007) Comparing a generic and individualized information decision support intervention for men newly diagnosed with localized prostate cancer. Cancer Nurs 30(5):E7–E15. https://doi.org/10.1097/01.NCC.0000290819.22195.d6
Williams-Piehota PA, McCormark LA, Treiman K et al (2008) Health information styles among participants in a prostate cancer screening informed decision-making intervention. Health Educ Res 23(3):440–453. https://doi.org/10.1093/her/cyn011
Scherr KA, Fagerlin A, Hofer T, Scherer LD, Holmes-Rovner M, Williamson LD, Kahn VC, Montgomery JS, Greene KL, Zhang B, Ubel PA (2017) Physician recommendations trump patient preferences in prostate cancer treatment decisions. Med Decis Mak 37(1):56–69. https://doi.org/10.1177/0272989X16662841
Shea-Budgell MA, Kostaras X, Myhill KP, Hagen NA (2014) Information needs and sources of information for patients during cancer follow-up. Curr Oncol 21(4):165–173. https://doi.org/10.3747/co.21.1932
Elwyn G, O'Connor A, Stacey D, Volk R, Edwards A, Coulter A, Thomson R, Barratt A, Barry M, Bernstein S, Butow P, Clarke A, Entwistle V, Feldman-Stewart D, Holmes-Rovner M, Llewellyn-Thomas H, Moumjid N, Mulley A, Ruland C, Sepucha K, Sykes A, Whelan T, International Patient Decision Aids Standards (IPDAS) Collaboration (2006) Developing a quality criteria framework for patient decision aids: online international Delphi consensus process. BMJ 333(7565):417–410. https://doi.org/10.1136/bmj.38926.629329.AE
Hoffman R (2012) Improving the communication of benefits and harms of treatment strategies: decision AIDS for localized prostate cancer treatment decisions. J Natl Cancer Inst Monogr 2012(45):197–201. https://doi.org/10.1093/jncimonographs/lgs023
Acknowledgements
We would like to acknowledge the Director General of the Ministry of Health, Malaysia, for permission to conduct and publish this study. We also acknowledge the contribution of all the urology nurses who have help in data collection and recruitment. Finally, we would like to thank all the patients who participated in the study and acknowledge the grant from Universiti Putra Malaysia (RUGS 2-2012-2093).
Availability of Data and Material
Available on request from researchers with approval from Unversiti Putra Malaysia.
Funding
Financial support for this study was provided entirely by a grant from University Putra Malaysia. The funding agreement ensured the authors’ independence in designing the study, interpreting the data, writing, and publishing the report.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflicts of Interest
The Authors declares that there is no conflict of interest.
Ethics Approval
Ethics approval was obtained from the Malaysian Ministry of Health Medical Research Ethics Committee (NMRR-14-494-20,143), Medical Research Ethic Committee of University of Malaya (20144-81) and Medical Research Ethic Committee of Universiti Putra Malaysia.
Consent to Participate and for Publication
The participants completed a written consent procedure which included consent to participate and publication of their data.
Additional information
Publisher’s Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Jalil, N.B., Lee, P.Y., Nor Afiah, M.Z. et al. Effectiveness of Decision Aid in Men with Localized Prostate Cancer: a Multicenter Randomized Controlled Trial at Tertiary Referral Hospitals in an Asia Pacific Country. J Canc Educ 37, 169–178 (2022). https://doi.org/10.1007/s13187-020-01801-6
Published:
Issue Date:
DOI: https://doi.org/10.1007/s13187-020-01801-6